Kunikazu Tanji

Kunikazu Tanji

Auto-generated profile, based on publicly available information

Kunikazu Tanji

Department of Neuropathology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki 036-8562, Japan

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2015 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
KTKunikazu Tanji
Kunikazu Tanji
YMYasuo Miki
Yasuo Miki
AMAtsushi Maruyama
Atsushi Maruyama
JMJunsei Mimura
Junsei Mimura
TMTomoh Matsumiya
Tomoh Matsumiya
KWKoichi Wakabayashi
Koichi Wakabayashi

1 April 2018 in Neurobiology of Disease
Verified
Journal Article
Closed access
KTKunikazu Tanji
Kunikazu Tanji
FMFumiaki Mori
Fumiaki Mori
YMYasuo Miki
Yasuo Miki
JUJun Utsumi
Jun Utsumi
HSHidenao Sasaki
Hidenao Sasaki
KWKoichi Wakabayashi
Koichi Wakabayashi

1 July 2019 in Neurobiology of Disease
Verified
Journal Article
Closed access
KTKunikazu Tanji
Kunikazu Tanji
YMYasuo Miki
Yasuo Miki
FMFumiaki Mori
Fumiaki Mori
YNYoshikazu Nikaido
Yoshikazu Nikaido
HNHidemi Narita
Hidemi Narita
KWKoichi Wakabayashi
Koichi Wakabayashi

1 September 2018 in Neuroscience Letters
Verified
Journal Article
Closed access
YMYasuo Miki
Yasuo Miki
KTKunikazu Tanji
Kunikazu Tanji
FMFumiaki Mori
Fumiaki Mori
JUJun Utsumi
Jun Utsumi
HSHidenao Sasaki
Hidenao Sasaki
KWKoichi Wakabayashi
Koichi Wakabayashi

12 August 2022 in Neuropathology and Applied Neurobiology
Verified
Journal Article
Closed access
YMYasuo Miki
Yasuo Miki
KTKunikazu Tanji
Kunikazu Tanji
KSKana Shinnai
Kana Shinnai
MTMakoto T. Tanaka
Makoto T. Tanaka
MELEK FIRAT ALTAYMELEK FIRAT ALTAY
MELEK FIRAT ALTAY
KWKoichi Wakabayashi
Koichi Wakabayashi

1 November 2009 in Journal of Neuropathology & Experimental Neurology
Verified
Journal Article
Open access
PDF file
FMFumiaki Mori
Fumiaki Mori
KTKunikazu Tanji
Kunikazu Tanji
YMYasuo Miki
Yasuo Miki
KWKoichi Wakabayashi
Koichi Wakabayashi
Cystatin C (CC), a cysteine protease inhibitor involved in protein degradation, is a marker of Bunina bodies in lower motor neurons in amyotrophic lateral sclerosis (ALS). TAR-DNA binding protein-43 (TDP-43)-immunoreactive inclusions are also histological hallmarks of ALS but whether CC is found in motor neurons with or without TDP-43-positive inclusions in ALS is not known. To determine whether inclusion body formation affects cytoplasmic CC immunoreactivity, we examined spinal cords from 9 ALS patients and 12 control subjects by immunohistochemistry. Most anterior horn cells (AHCs) showed moderate to intense immunoreactivity in controls, whereas CC immunoreactivity was markedly decreased in AHCs in ALS cases. The proportion of CC-immunolabeled AHCs was reduced regardless of whether they contained Bunina bodies. In contrast, the proportion of CC-immunolabeled AHCs was significantly reduced in those with TDP-43 inclusions. Cystatin C immunoreactivity of astrocytes in the spinal gray matter and white matter in ALS was significantly decreased compared with controls. These findings suggest that the formation of TDP-43 inclusions, but not of Bunina bodies, may be linked to the content of CC in spinal motor neurons and that perturbations in endogenous levels of CC in neuronal and glial cells may be part of the neurodegenerative processes in ALS.